Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders.
about
Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3A role for Seven in Absentia Homolog (Siah1a) in metabotropic glutamate receptor signalingMetabotropic glutamate receptors in the basal ganglia motor circuitEnhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionAlterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations.Role of corticostriatal circuits in context-induced reinstatement of drug seekingGroup I metabotropic glutamate receptor-mediated activation of PKC gamma in the nucleus accumbens core promotes the reinstatement of cocaine seeking.Therapeutic potential of metabotropic glutamate receptor modulators.Glutamatergic plasticity and alcohol dependence-induced alterations in reward, affect and cognition.Review. Context-induced relapse to drug seeking: a reviewStimulation of mGluR5 in the accumbens shell promotes cocaine seeking by activating PKC gammaMetabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.Efficient implementation of a real-time estimation system for thalamocortical hidden Parkinsonian properties.Glutamate receptors as therapeutic targets for Parkinson's disease.Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Chemical anatomy of pallidal afferents in primates.Effect of glutamate and riluzole on manganese-induced apoptotic cell signaling in neuronally differentiated mouse P19 Cells.The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats.Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus.Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.Presynaptic localization of an AMPA-type glutamate receptor in corticostriatal and thalamostriatal axon terminals.Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5.Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.Repetitive activation of glutamatergic inputs evokes a long-lasting excitation in rat globus pallidus neurons in vitro.Impact of the Chronic Omega-3 Fatty Acids Supplementation in Hemiparkinsonism Model Induced by 6-Hydroxydopamine in Rats.Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).Marked Involvement of the Striatal Efferent System in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain.Improved Syntheses of the Mglu₅ Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling.
P2860
Q24616083-D966730D-B92C-47E1-9169-50DF86DA44DBQ24806525-C3821192-A302-488F-9CEA-C3102A182B72Q28280931-47C4C33F-6B4C-4674-9EC0-E0C028A7C71AQ28585008-B5D236BF-EC06-4D0C-9284-4ED0519E8628Q33626978-998A079B-524F-43C7-96A9-4B1DB1228EFBQ33754643-DFFA3F99-01DE-4625-B2C6-1433E41A8FFAQ34685551-EF2F865E-847B-48CF-AF22-2442918B736FQ35185615-C59B4961-226E-4EE8-AC93-24ECE31A8768Q35234451-137604F1-D465-4853-80B5-B1182D13320EQ35778704-758084EF-7760-49F6-B81D-15EEF1A50B86Q36372481-12546B66-1741-4B3E-923E-53F05D074FB3Q37024146-8216AD4B-E6FF-4322-B63C-EE35E1D335DFQ37130953-565EB5F9-9F12-40D6-A258-31BF8182364DQ37358665-4907BF25-9B40-4BFF-8294-70EA61E75ED7Q37571369-ACF9C541-E77E-48AE-A745-B3FCC09A37B2Q37585401-486C111E-C58F-4730-A07A-4A70D2300FE7Q37782115-E31AA416-924B-4E1F-A427-FC696A94FD1EQ37924629-D2E85EDE-E362-4949-BE40-5DA44072E10EQ38793660-0D02E653-975A-4340-9E4E-A5F9D59CC795Q39356957-4815DE28-A51D-48B1-83A2-286710A52461Q39604782-309FADCA-4C50-4BAE-BCFB-2F040EE9FC97Q42410416-EAF6AF56-5FB1-4605-A94D-8D829ED8175BQ44590909-654EF2C3-0E4F-4FC0-BAED-3240129E6093Q44811440-681A5A61-02AE-496F-BBBD-860FF8298570Q45194972-3D1E356A-5561-4389-83F0-50790E96F5EDQ46535378-0EC41C33-7848-4B22-88DD-B0FE7669E13FQ47695530-47CD0F48-2E1C-4D46-9833-F4EE265EC02CQ48243272-60C20F71-52F4-41E5-8170-F67B2CB99D93Q48308115-809410CF-FEDD-436F-A4BD-0556DFF039FBQ48418240-80622F98-0F74-4025-A3D2-B4F0D1305128Q48595216-87C5B144-740A-47CC-AAAB-0942C0A4B8D5Q51679825-DB6EC64D-46BC-4FDD-AB8D-E0E72705F8F7Q53423558-244F18D8-D58D-4204-8291-D0CBF2C0238BQ55236242-1A8DF4FD-D285-4D7F-9F7A-E7D5BEA1217A
P2860
Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Distribution and roles of meta ...... disease and related disorders.
@ast
Distribution and roles of meta ...... disease and related disorders.
@en
Distribution and roles of meta ...... disease and related disorders.
@nl
type
label
Distribution and roles of meta ...... disease and related disorders.
@ast
Distribution and roles of meta ...... disease and related disorders.
@en
Distribution and roles of meta ...... disease and related disorders.
@nl
prefLabel
Distribution and roles of meta ...... disease and related disorders.
@ast
Distribution and roles of meta ...... disease and related disorders.
@en
Distribution and roles of meta ...... disease and related disorders.
@nl
P2093
P1476
Distribution and roles of meta ...... disease and related disorders.
@en
P2093
P304
P356
10.1016/S0163-7258(00)00098-X
P577
2000-12-01T00:00:00Z